Table 1. Treatment timepoints available from the Hedge et al.’s dataset.

Cell lines	0.1 μM lapatinib	1 μM lapatinib	0.1% DMSO
SKBR-3	6, 12 and 24 hours	6 and 12 hours	0, 2, 6, 12, 24 hours
BT-474	2, 6, 12, 24 hours
T-47D		6, 12 and 24 hours
MDA-MB-468